Top

Archives of Gynecology and Obstetrics

Published in:

01-07-2017 | Review

Cytomegalovirus infection in pregnancy

Authors: Karl Oliver Kagan, Klaus Hamprecht

Published in: Archives of Gynecology and Obstetrics | Issue 1/2017

Abstract

Purpose

Due to the severe risk of long-term sequelae, prenatal cytomegalovirus infection is of particular importance amongst intrauterine viral infections. This review summarizes the current knowledge about CMV infection in pregnancy.

Methods

A search of the Medline and Embase database was done for articles about CMV infection in pregnany. We performed a detailed review of the literature in view of diagnosis, epidemiology and management of CMV infection in pregnancy.

Results

The maternal course of the infection is predominantly asymptomatic; the infection often remains unrecognized until the actual fetal manifestation. Typical ultrasound signs that should arouse suspicion of intrauterine CMV infection can be distinguished into CNS signs such as ventriculomegaly or microcephaly and extracerebral infection signs such as hepatosplenomegaly or hyperechogenic bowel. Current treatment strategies focus on hygienic measures to prevent a maternal CMV infection during pregnancy, on maternal application of hyperimmunoglobulines to avoid materno-fetal transmission in case of a maternal seroconversion, and on an antiviral therapy in case the materno-fetal transmission have occurred.

Conclusion

CMV infection in pregnancy may result in a severe developmental disorder of the newborn. This should be taken into account in the treatment of affected and non-affected pregnant women.

Kagan KO, Goelz R, Hamprecht K (2016) Cytomegalovirusinfektion in der Schwangerschaft. Gynäkologe. doi:10.1007/s00129-016-3923-0

Enders G, Daiminger A, Bäder U et al (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52:244–246. doi:10.1016/j.jcv.2011.07.005 CrossRefPubMed

Picone O, Vauloup-Fellous C, Cordier AG et al (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33:751–758. doi:10.1002/pd.4118 CrossRefPubMed

Revello MG, Furione M, Rognoni V et al (2014) Cytomegalovirus DNAemia in pregnant women. J Clin Virol 61:590–592. doi:10.1016/j.jcv.2014.10.002 CrossRefPubMed

Hamprecht K (2017) Update CMV, personal communication

Kenneson A, Cannon MJ (2007) Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 17:253–276. doi:10.1002/rmv.535 CrossRefPubMed

Britt W (2015) Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol 204:263–271. doi:10.1007/s00430-015-0399-9 CrossRefPubMed

De Paschale M, Agrappi C, Manco MT et al (2009) Incidence and risk of cytomegalovirus infection during pregnancy in an urban area of Northern Italy. Infect Dis Obstet Gynecol. doi:10.1155/2009/206505 PubMedPubMedCentral

Hamprecht K, Jahn G (2007) Human cytomegalovirus and congenital virus infection. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50:1379–1392. doi:10.1007/s00103-007-0194-x CrossRefPubMed

10.

Yinon Y, Farine D, Yudin MH (2010) Screening, diagnosis, and management of cytomegalovirus infection in pregnancy—PubMed—NCBI. Obstet Gynecol Surv 65:736–743. doi:10.1097/OGX.0b013e31821102b4 CrossRefPubMed

11.

Manicklal S, Emery VC, Lazzarotto T et al (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86–102. doi:10.1128/CMR.00062-12 CrossRefPubMedPubMedCentral

12.

Society for Maternal-Fetal Medicine (SMFM), Hughes BL, Gyamfi-Bannerman C (2016) Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol 214:B5–B11. doi:10.1016/j.ajog.2016.02.042 CrossRef

13.

Lazzarotto T, Boppana SB (2013) The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev 26:86–102. doi:10.1128/CMR.00062-12 CrossRefPubMedPubMedCentral

14.

AWMF (2014) Labordiagnostik schwangerschaftsrelevanter Virusinfektionen S2 k-Leitlinie AWMF Registernummer 0093/001. 1–209

15.

Hyde TB, Schmid DS, Cannon MJ (2010) Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 20:311–326. doi:10.1002/rmv.659 CrossRefPubMed

16.

Yamamoto AY, Mussi-Pinhata MM, Boppana SB et al (2010) Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol 202(297):e1–e8. doi:10.1016/j.ajog.2009.11.018

17.

Wang C, Zhang X, Bialek S, Cannon MJ (2011) Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 52:e11–e13. doi:10.1093/cid/ciq085 CrossRefPubMed

18.

Voigt S, Schaffrath Rosario A, Mankertz A (2016) Cytomegalovirus seroprevalence among children and adolescents in Germany: data from the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), 2003–2006. Open Forum Infect Dis. doi:10.1093/ofid/ofv193 PubMed

19.

Bodéus M, Kabamba-Mukadi B, Zech F et al (2010) Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. J Clin Virol 47:201–202. doi:10.1016/j.jcv.2009.11.009 CrossRefPubMed

20.

Lipitz S, Yinon Y, Malinger G et al (2013) Risk of cytomegalovirus-associated sequelae in relation to time of infection and findings on prenatal imaging. Ultrasound Obstet Gynecol 41:508–514. doi:10.1002/uog.12377 CrossRefPubMed

21.

Bilavsky E, Pardo J, Attias J et al (2016) Clinical implications for children born with congenital cytomegalovirus infection following a negative amniocentesis. Clin Infect Dis 63:33–38. doi:10.1093/cid/ciw237 CrossRefPubMed

22.

Hamprecht K, Bissinger AL, Arellano-Galindo J et al (2014) Intrafamilial transmission of human cytomegalovirus (HCMV): long-term dynamics of epitope-specific antibody response in context of avidity maturation. J Clin Virol 60:119–126. doi:10.1016/j.jcv.2014.03.006 CrossRefPubMed

23.

Schoppel K, Kropff B, Schmidt C et al (1997) The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. J Infect Dis 175:533–544CrossRefPubMed

24.

Prince HE, Lapé-Nixon M (2014) Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin Vaccine Immunol 21:1377–1384. doi:10.1128/CVI.00487-14 CrossRefPubMedPubMedCentral

25.

Karacan M, Batukan M, Çebi Z et al (2014) Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status—PubMed—NCBI. Arch Gynecol Obstet 290:1115–1120. doi:10.1007/s00404-014-3340-3 CrossRefPubMed

26.

Kling C, Kabelitz D (2014) Congenital HCMV and assisted reproduction: why not use the chance for primary screening? Arch Gynecol Obstet 291:1205–1211. doi:10.1007/s00404-014-3583-z CrossRefPubMed

27.

Leruez-Ville M, Stirnemann J, Sellier Y et al (2016) Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis. Am J Obstet Gynecol 215(342):e1–e9. doi:10.1016/j.ajog.2016.03.052

28.

Malinger G, Lev D, Lerman-Sagie T (2011) Imaging of fetal cytomegalovirus infection. Fetal Diagn Ther 29:117–126. doi:10.1159/000321346 CrossRefPubMed

29.

Teissier N, Fallet-Bianco C, Delezoide A-L et al (2014) Cytomegalovirus-induced brain malformations in fetuses. J Neuropathol Exp Neurol 73:143–158. doi:10.1097/NEN.0000000000000038 CrossRefPubMed

30.

Gabrielli L, Bonasoni MP, Lazzarotto T et al (2009) Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 46:S16–S21. doi:10.1016/j.jcv.2009.09.026 CrossRefPubMed

31.

Hui L, Wood G (2014) Perinatal outcome after maternal primary cytomegalovirus infection in the first trimester: a practical update and counseling aid. Prenat Diagn 35:1–7. doi:10.1002/pd.4497 CrossRefPubMed

32.

Guerra B, Simonazzi G, Puccetti C et al (2008) Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 198:380.e1–380.e7. doi:10.1016/j.ajog.2007.09.052 CrossRef

33.

Benoist G, Salomon LJ, Jacquemard F et al (2008) The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 115:823–829. doi:10.1111/j.1471-0528.2008.01714.x CrossRefPubMed

34.

Liesnard C, Donner C, Brancart F et al (2000) Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 95:881–888PubMed

35.

Enders G, Bäder U, Lindemann L et al (2001) Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 21:362–377. doi:10.1002/pd.59 CrossRefPubMed

36.

Donner C, Liesnard C, Brancart F, Rodesch F (1994) Accuracy of amniotic fluid testing before 21 weeks’ gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn 14:1055–1059CrossRefPubMed

37.

Enders M, Daiminger A, Exler S et al (2017) Prenatal diagnosis of congenital cytomegalovirus infection in 115 cases: a 5 years’ single center experience. Prenat Diagn 198:380. doi:10.1002/pd.5025

38.

Renzette N, Pokalyuk C, Gibson L et al (2015) Limits and patterns of cytomegalovirus genomic diversity in humans. Proc Natl Acad Sci USA 112:E4120–E4128. doi:10.1073/pnas.1501880112 CrossRefPubMedPubMedCentral

39.

Pass RF, Zhang C, Evans A et al (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360:1191–1199. doi:10.1056/NEJMoa0804749 CrossRefPubMedPubMedCentral

40.

Adler SP (2015) Prevention of maternal-fetal transmission of cytomegalovirus. EBIOM 2:1027–1028. doi:10.1016/j.ebiom.2015.08.004 CrossRef

41.

Hamilton ST, van Zuylen W, Shand A et al (2014) Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Rev Med Virol 24:420–433. doi:10.1002/rmv.1814 CrossRefPubMed

42.

Revello MG, Tibaldi C, Masuelli G et al (2015) Prevention of primary cytomegalovirus infection in pregnancy. EBIOM 2:1205–1210. doi:10.1016/j.ebiom.2015.08.003 CrossRef

43.

Maidji E, Nigro G, Tabata T et al (2010) Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J Pathol 177:1298–1310. doi:10.2353/ajpath.2010.091210 CrossRefPubMedPubMedCentral

44.

Nigro G, Adler SP, La Torre R et al (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350–1362. doi:10.1056/NEJMoa043337 CrossRefPubMed

45.

Revello MG, Lazzarotto T, Guerra B et al (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370:1316–1326. doi:10.1056/NEJMoa1310214 CrossRefPubMed

46.

Buxmann H, Stackelberg OMV, Schlößer RL et al (2012) Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 40:1–8. doi:10.1515/jpm-2011-0257 CrossRef

47.

Rawlinson WD, Boppana SB, Fowler KB et al (2017) Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. doi:10.1016/S1473-3099(17)30143-3 PubMed

48.

Thürmann PA, Sonnenburg-Chatzopoulos C, Lissner R (1995) Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation. Eur J Clin Pharmacol 49:237–242CrossRefPubMed

49.

Hamprecht K, Kagan KO, Goelz R (2014) Hyperimmune globulin to prevent congenital CMV infection. N Engl J Med 370:2543. doi:10.1056/NEJMc1405377#SA1 CrossRefPubMed

50.

Visentin S, Manara R, Milanese L et al (2012) Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 55:497–503. doi:10.1093/cid/cis423 CrossRefPubMed

51.

Malek A, Sager R, Kuhn P et al (1996) Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 36:248–255CrossRefPubMed

52.

Leruez-Ville M, Ghout I, Bussières L et al (2016) In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicentre, open-label, phase II study. Am J Obstet Gynecol. doi:10.1016/j.ajog.2016.04.003

53.

Goderis J, De Leenheer E, Smets K et al (2014) Hearing loss and congenital CMV infection: a systematic review. Pediatrics 134:972–982. doi:10.1542/peds.2014-1173 CrossRefPubMed

54.

Fowler KB, McCollister FP, Sabo DL et al (2017) A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics 139:e20162128. doi:10.1542/peds.2016-2128 CrossRefPubMed

55.

Gantt S, Dionne F, Kozak FK et al (2016) Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. JAMA Pediatr 170:1173–1178. doi:10.1001/jamapediatrics.2016.2016 CrossRefPubMed

56.

Kimberlin DW, Lin C-Y, Sánchez PJ et al (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143:16–25CrossRefPubMed

57.

Oliver SE, Cloud GA, Sánchez PJ et al (2009) Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 46(Suppl 4):S22–S26. doi:10.1016/j.jcv.2009.08.012 CrossRefPubMedPubMedCentral

58.

Kimberlin DW, Jester PM, Sánchez PJ et al (2015) Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372:933–943. doi:10.1056/NEJMoa1404599 CrossRefPubMedPubMedCentral

Title: Cytomegalovirus infection in pregnancy
Authors: Karl Oliver Kagan
Klaus Hamprecht
Publication date: 01-07-2017
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 1/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-017-4380-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Cytomegalovirus infection in pregnancy

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Presentation and management of vesicovaginal fistulae after delivery at a German women’s hospital

Current strategies in the diagnosis of endometrial cancer

Diagnosis and management of heterotopic pregnancy following embryo transfer: clinical analysis of 55 cases from a single institution

Effectiveness of the contemporary treatment of preterm labor: a comparison with a historical cohort

The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products

AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS)